Owc Pharmaceutical Research Quick Ratio (OWCP) starting from the third quarter 2019 to third quarter 2018, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Owc Pharmaceutical Research Corp.  (OWCP)

Owc Pharmaceutical Research's Quick Ratio

OWCP's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2019, Quick Ratio fell to 2.7 below Owc Pharmaceutical Research Corp. average.

Within Medical Equipment & Supplies industry 48 other companies have achieved higher Quick Ratio than Owc Pharmaceutical Research in third quarter 2019. While Quick Ratio total ranking has improved so far during the Q3 2019 to 983, from total ranking in the second quarter 2019 at 994.

Explain Quick Ratio?
How much Cash & cash equivalents OWCP´s has?
What are OWCP´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OWCP Quick Ratio (Sep 30 2019)
Q3		 (Jun 30 2019)
Q2		 (Mar 31 2019)
Q1		 (Dec 31 2018)
Q4		 (Sep 30 2018)
Q3
Y / Y Current Liabilities Change 35.38 % 36.18 % 117.06 % 61.92 % 92.65 %
Y / Y Cash & cash equivalent Change -65.27 % -60.42 % 304.88 % 256.91 % 278.93 %
Quick Ratio MRQ 2.7 3.57 5.5 7.91 10.52
OWCP's Total Ranking # 983 # 994 # 496 # 402 # 297
Seq. Current Liabilities Change 5.23 % 1.38 % 16.21 % 9.2 % 5.86 %
Seq. Cash & cash equivalent Change -20.38 % -34.29 % -19.17 % -17.89 % -9.26 %



Quick Ratio third quarter 2019 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 49
Healthcare Sector # 471
Overall Market # 983


Quick Ratio Statistics
High Average Low
31.21 9.76 0.02
(Mar 31 2015)   (Dec 31 2013)




Financial Statements
Owc Pharmaceutical Research's Current Liabilities $ 1 Millions Visit OWCP's Balance sheet
Owc Pharmaceutical Research's Cash & cash equivalent $ 1 Millions Visit OWCP's Balance sheet
Source of OWCP's Sales Visit OWCP's Sales by Geography


Cumulative Owc Pharmaceutical Research's Quick Ratio

OWCP's Quick Ratio for the trailling 12 Months

OWCP Quick Ratio

 (Sep 30 2019)
12 Months		 (Jun 30 2019)
12 Months		 (Mar 31 2019)
12 Months		 (Dec 31 2018)
12 Months		 (Sep 30 2018)
12 Months
Y / Y Current Liabilities TTM Growth 56.11 % 70.69 % 94.31 % 80.93 % 89.5 %
Y / Y Cash & cash equivalent TTM Growth -9.13 % 65.97 % 264.16 % 136.28 % 110.03 %
Quick Ratio TTM 4.77 6.61 8.76 8.97 8.19
Total Ranking TTM # 4486 # 4094 # 145 # 3902 # 3953
Seq. Current Liabilities TTM Growth 7.61 % 7.94 % 18.9 % 13.04 % 17.66 %
Seq. Cash & cash equivalent TTM Growth -22.35 % -18.57 % 16.19 % 23.68 % 41.83 %

Quick ratio ranking by company, industry and sector >> Back to OWCP Financial Strength Comparisons >> Go to Compare OWCP Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2019 to $0.54 millions, cumulative Quick Ratio decreased to 4.77 below the Owc Pharmaceutical Research Corp. average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 188 other companies have achieved higher Quick Ratio than Owc Pharmaceutical Research. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2019 from 4094 to 4486.

Explain Quick Ratio?
How much Cash & cash equivalents OWCP´s has?
What are OWCP´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 189
Healthcare Sector # 875
Within the Market # 4486


trailing twelve months Quick Ratio Statistics
High Average Low
21.18 8.7 2.6
(Mar 31 2015)   (Sep 30 2016)




Companies with similar Quick Ratio in the quarter ending Sep 30 2019, within Medical Equipment & Supplies Industry Quick RatioSep 30 2019 MRQ Cash & cash equivalentSep 30 2019 MRQ Current Liabilities
Harpoon Therapeutics Inc   7.27 $ 121.227  Millions$ 16.686  Millions
Iradimed Corporation  6.83 $ 38.637  Millions$ 5.653  Millions
Axonics Inc   6.53 $ 101.542  Millions$ 15.543  Millions
Brainsway Ltd   6.41 $ 21.674  Millions$ 3.379  Millions
Apyx Medical Corp  6.34 $ 62.272  Millions$ 9.823  Millions
Vapotherm Inc   6.21 $ 83.522  Millions$ 13.444  Millions
Transmedics Group Inc   6.10 $ 88.272  Millions$ 14.479  Millions
Masimo Corp  5.99 $ 633.360  Millions$ 105.728  Millions
Axogen inc   5.98 $ 100.066  Millions$ 16.743  Millions
Shockwave Medical Inc   5.88 $ 114.098  Millions$ 19.391  Millions
Orasure Technologies Inc  5.66 $ 163.680  Millions$ 28.936  Millions
Tactile Systems Technology Inc   5.48 $ 44.734  Millions$ 8.159  Millions
Catheter Precision Inc   5.07 $ 40.476  Millions$ 7.982  Millions
Abiomed Inc   4.79 $ 445.320  Millions$ 92.907  Millions
Glaukos Corp  4.62 $ 152.919  Millions$ 33.103  Millions
Intersect Ent Inc   4.61 $ 89.227  Millions$ 19.355  Millions
Invivo Therapeutics Holdings Corp   4.42 $ 8.140  Millions$ 1.841  Millions
Envue Medical Inc   4.33 $ 2.258  Millions$ 0.522  Millions
Biolife Solutions Inc   4.29 $ 21.205  Millions$ 4.944  Millions
Pro dex Inc   4.07 $ 9.629  Millions$ 2.366  Millions
Inogen Inc   4.01 $ 200.645  Millions$ 50.043  Millions
Neuronetics Inc   3.84 $ 82.370  Millions$ 21.473  Millions
Staar Surgical Co  3.75 $ 112.327  Millions$ 29.972  Millions
Electrocore Inc   3.41 $ 33.488  Millions$ 9.809  Millions
Irhythm Holdings Inc   3.36 $ 152.725  Millions$ 45.467  Millions
Sientra Inc   3.26 $ 120.915  Millions$ 37.085  Millions
Soleno Therapeutics Inc  3.25 $ 11.225  Millions$ 3.454  Millions
Intuitive Surgical Inc   3.11 $ 2,897.600  Millions$ 930.900  Millions
Soliton Inc   3.11 $ 8.506  Millions$ 2.734  Millions
Inspiremd Inc   3.08 $ 7.154  Millions$ 2.323  Millions

Date modified: 2026-06-22T16:30:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.